It was recently shown that both PPARβ/δ and PPARα receptors were necessary for adipose tissue reduction driven by the PPARβ/δ agonist GW501516 and subsequent development of hepatic steatosis, with PPARβ/δ working upstream of PPARα [131]. Here, PPARD is linked to Hepatic steatosis.